Publication | Closed Access

Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells

Neuro-oncologyGlioma-initiating CellsTumor InnervationGliomaBone Morphogenic ProteinReceptor (Biochemistry)NeuroscienceTumourigenic PotentialMedicineCell BiologyCell SignalingOsteocalcinTumor Biology